Gulf

War Illness Research Program (DoD/CDMRP):

Newly-funded Projects in 2015 (FY14 Funds)
PREPARED BY: VETERANS FOR COMMON SENSE. Last Updated February 16, 2016

The treatment-focused Gulf War Illness Research Program (GWIRP) is one of several medical
research programs in the Congressionally Directed Medical Research Program (CDMRP) portfolio
within the U.S. Department of Defense (DoD). The GWIRP competitively funds innovative Gulf
War Illness research to identify effective treatments, improve definition and diagnosis, and better
understand pathobiology and symptoms. Its vision is to improve the health and lives of veterans
who have Gulf War Illness.i
It was initiated by Congress in federal fiscal year 2006 (FY06) to provide support for medical
research of exceptional scientific merit related to the health effects of deployment on U.S.
Warfighters during the 1991 Persian Gulf War.i This paper lists each of the studies funded by the
GWIRP in 2015 (FY14 funds), with hyperlinks to each projects lay and scientific abstracts.

PILOT STUDIES OF TREATMENTS FUNDED IN 2015

1. D-Cycloserine: A Novel Treatment for Gulf War Illness, R. Toomey, Boston Univ. Medical Campus,
MA (GW140069)
2. Effect of Diet on Gulf War Illness: A Pilot Study, A. Tuteja, Western Institute for Biomedical
Research, UT (GW140074)
3. Vagus Nerve Stimulation as a Treatment Strategy for Gulf War Illness, L. Shapiro, Texas A&M
Univ. System Health Science Center, TX (GW140097)
4. Designing a Successful Acupuncture Treatment Program for Gulf War Illness, L. Conboy, New
England School of Acupuncture, Boston, MA (GW140138)
5. Extending Benefits of Q10: Mitochondrial Cocktail for Gulf War Illness, B. Golomb, Univ. of Calif.San Diego, CA (GW140146)
6. Testing the Model: A Phase I/II Randomized Double Blind Placebo Control Trial of Targeted
Therapeutics: Liposomal Glutathione and Curcumin, N. Klimas, South Florida Veterans Affairs
Foundation for Research and Education, Inc., FL & R. Deth, Nova Southeastern Univ., FL
(GW140153, GW140153P1)
7. Double-Blind, Placebo-Controlled Crossover Study of the Anti-Inflammatory Compound
Anatabine to Treat Pain in GWI Patients, F. Crawford, Roskamp Institute, FL (GW140159)
8. Vagus Nerve Stimulation: A Noninvasive Treatment to Improve the Health of Gulf Veterans with
Gulf War Illness, B. Natelson, Beth Israel Medical Center, NY (GW140157)

STUDIES OF UNDERLYING MECHANISMS AND BIOMARKERS FUNDED IN 2015

9. Vascular and Skeletal Muscle Function in Gulf War Veterans Illness, S. Kinlay, Boston VA
Research Institute, MA (GW140035)
10. Muscle Mitochondrial Assessments in Gulf War Illness, B. Golomb, Univ. of Calif.-San Diego, CA
(GW140045)
11. Gulf War Illness as a Brain Autoimmune Disorder, A. Georgopolous, Univ. of Minn.-Twin Cities,
MN (GW140053)
12. START and STOPP in GWI, J. Baraniuk, Georgetown Univ., DC (GW140064)
13. Neurovascular and Autonomic Dysfunction Associated with Gulf War Illness Pain, B. Cooper, Univ.
of Fla., FL (GW140066)
14. An Integrated Genomics and Cell Biology Approach to Correlate Novel GWI Indicators of
Infections and Neuroinflammatory Mechanisms with Targeted Drug Therapy, P. Waziry, Nova
Southeastern Univ., FL (GW140077)
15. Preclinical Treatment of an Organophosphate Model of Gulf War Illness, H. Speed, Univ. of Texas
Southwestern Medical Center at Dallas, TX (GW140091)

16. Microtubule Abnormalities Underlying Gulf War Illness in Neurons from Human-Induced
Pluripotent Cells, P. Baas, Drexel Univ., PA (GW140086)
17. Studies of Biomarkers and Brain Mechanisms of Gulf War Illness, D.C. Shungu, Weill Cornell
School of Medicine, Cornell Univ., NY (GW140114)
18. Novel Autoantibody Serum and Cerebrospinal Fluid Biomarkers in Veterans with Gulf War Illness,
K. Sullivan, Boston Univ. Medical Campus, MA & M. Abou-Donia, Duke Univ., NC (GW140140,
GW140140P2)
19. High-Fidelity Design of Multimodal Restorative Interventions in Gulf War Illness, G. Broderick,
Nova Southeastern Univ., FL & D. Whitley, Colo. State Univ., CO (GW140142)
20. An Objective Blood Test from Stimulated Gene Expression for Classification and Outcome
Assessment in Clinical Trials of Gulf War Illness, Dr.s R. Haley & E. Wakeland, Univ. of Texas
Southwestern Medical Center at Dallas, TX (GW140158, GW140158P1)
21. Diagnosis of Late-Stage, Early-Onset, Small-Fiber Polyneuropathy, A.L. Oaklander, Massachusetts
General Hospital, MA & J. Serrador, Veterans Biomedical Research Institute, NJ (GW140169,
GW140169P1)

i Gulf War Illness Research Program (GWIRP), Congressionally Directed Medical Research Program, U.S
Department of Defense, Program Website. Retrieved Jan. 24, 2016, http://cdmrp.army.mil/gwirp.